Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Pietsch

Showing results (41-50 of 388) with videos related to

Pageof 39
Sort By:
Pediatric Blood & Cancer|December 1, 2005
Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?Stefan Aretz, Arend Koch, Siegfried Uhlhaas, et al.
Neuro-Oncology|December 4, 2008
Pediatric giant cell glioblastoma: New insights into a rare tumor entityMichael Karremann, Sandra Butenhoff, Ulrike Rausche, et al.
The Journal of Molecular Diagnostics : JMD|September 18, 2010
A pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samplesPrashanth Setty, Jennifer Hammes, Thomas Rothämel, et al.
Oncotarget|February 5, 2017
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibitionRogerio B Craveiro, Michael Ehrhardt, Julia Velz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91Beate Timmermann, Rolf-Dieter Kortmann, Joachim Kühl, et al.
Neoplasia (New York, N.Y.)|July 2, 2009
Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhoodValentina Vladimirova, Thomas Mikeska, Andreas Waha, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|August 6, 2011
Sensitive determination of BRAF copy number in clinical samples by pyrosequencingPrashanth Setty, Marco Gessi, Anke Waha, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 24, 2017
Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0aTill Holsten, Konstantinos Tsiakas, Uwe Kordes, et al.
Pediatric Blood & Cancer|January 28, 2014
Ependymoblastoma of the brainstem: MRI findings and differential diagnosisJohannes Nowak, Carolin Seidel, Torsten Pietsch, et al.
Journal of Cellular and Molecular Medicine|November 15, 2022
The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitroLeonie F Schoen, Rogerio B Craveiro, Torsten Pietsch, et al.
Pageof 39

Showing results (41-50 of 388) with videos related to

Sort By:
Pageof 39
Pediatric Blood & Cancer|December 1, 2005
Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?Stefan Aretz, Arend Koch, Siegfried Uhlhaas, et al.
Neuro-Oncology|December 4, 2008
Pediatric giant cell glioblastoma: New insights into a rare tumor entityMichael Karremann, Sandra Butenhoff, Ulrike Rausche, et al.
The Journal of Molecular Diagnostics : JMD|September 18, 2010
A pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samplesPrashanth Setty, Jennifer Hammes, Thomas Rothämel, et al.
Oncotarget|February 5, 2017
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibitionRogerio B Craveiro, Michael Ehrhardt, Julia Velz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91Beate Timmermann, Rolf-Dieter Kortmann, Joachim Kühl, et al.
Neoplasia (New York, N.Y.)|July 2, 2009
Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhoodValentina Vladimirova, Thomas Mikeska, Andreas Waha, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|August 6, 2011
Sensitive determination of BRAF copy number in clinical samples by pyrosequencingPrashanth Setty, Marco Gessi, Anke Waha, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 24, 2017
Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0aTill Holsten, Konstantinos Tsiakas, Uwe Kordes, et al.
Pediatric Blood & Cancer|January 28, 2014
Ependymoblastoma of the brainstem: MRI findings and differential diagnosisJohannes Nowak, Carolin Seidel, Torsten Pietsch, et al.
Journal of Cellular and Molecular Medicine|November 15, 2022
The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitroLeonie F Schoen, Rogerio B Craveiro, Torsten Pietsch, et al.
Pageof 39